Drug Detail

Information about Hydroxychloroquine + Sorafenib

Generic Name	Hydroxychloroquine + Sorafenib
IND	Hydroxychloroquine + Sorafenib
Brand Name (US)
Manufacturer
Drug Type
Delivery	Oral
Approval Status
Indications
Overall Strategy	KIT Protein Based + Oncogenic Signal Path Based
Strategy	Block KIT + Block Autophagy
Drug Category	Kit inhibitor + Autophagy inhibitor

Links
Trials of this drug
	Oral Hydroxychloroquine Plus Oral Sorafenib to Treat Patients With Refractory or Relapsed Solid Tumors

Trial results